SGYP


Biotech Beat: XOMA Corp (XOMA), Synergy Pharmaceuticals Inc (SGYP), MannKind Corporation (MNKD), CIGNA Corporation (CI)

XOMA Corp Stock Starts To Recover XOMA Corp (NASDAQ:XOMA) had an incredibly rough day in the market yesterday. After announcing that a recent Phase 3 …

Biotech Beat: MannKind Corporation (MNKD), Synergy Pharmaceuticals Inc (SGYP), Novogen Limited (NVGN) News

MannKind Corporation (NASDAQ:MNKD) stock is having a great day in the market today. When it comes to MNKD, one big concern for several …

Biotech Beat: MannKind Corporation (MNKD), Gilead Sciences, Inc. (GILD), Synergy Pharmaceuticals Inc (SGYP), Biocept Inc (BIOC)

Well, the Greek Debt Crisis has come to a conclusion, a default; and US stocks seem to be back to normal. This leaves …

Wednesday’s Morning Insights: Synergy Pharmaceuticals Inc (SGYP), Enteromedics Inc. (ETRM), Zogenix, Inc. (ZGNX), Onconova Therapeutics Inc (ONTX)

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) has increased $5.78 in mid-day trading to $8.

Stock Update (NASDAQ:SGYP): Synergy Pharmaceuticals Inc Initiates Second Phase 3 Clinical Trial of Plecanatide in Patients with Irritable Bowel Syndrome with Constipation

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) announced the initiation of the second of two pivotal phase 3 clinical trials evaluating the efficacy and safety of two …

Biotech Beat: Avalanche Biotechnologies Inc (AAVL), bluebird bio Inc (BLUE), Synergy Pharmaceuticals Inc (SGYP) News

Disparate results from two gene therapy developers are worth a mention in this week’s biotech recap. Avalanche Biotechnologies Inc (NASDAQ:AAVL) blew up spectacularly …

Analysts Positive on Synergy Pharmaceuticals Inc (SGYP) Following Positive Trial Data

On June 17, Synergy Pharmaceuticals Inc (NASDAQ:SGYP) announced positive results from the first Phase 3 Trial of plecanatide in patients with chronic idiopathic …

Canaccord Genuity Maintains Buy on Synergy Pharmaceuticals Inc Following Top-Line Results from plecanatide Trial

Canaccord Genuity analyst Corey Davis came out with a research report on Synergy Pharmaceuticals Inc (NASDAQ:SGYP) after the company announced positive top-line results from the …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts